When taken together with the significant association observed with cortical atrophy in AD patients, this suggests that the reduced levels of CSF NPTX2 are not due to neurodevelopmental factors but rather due to synaptic loss and dysfunction in AD patients. Here, NPTX2 is linked to Alzheimer disease.